ZENAS BIOPHARMA
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients. The company is headquartered in Florida, USA.
ZENAS BIOPHARMA
Social Links:
Industry:
Biopharma Health Care Pharmaceutical
Founded:
2020-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.zenasbio.com
Total Employee:
51+
Status:
Active
Total Funding:
318 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Content Delivery Network Global Site Tag
Similar Organizations
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals is a biopharmaceutical company that focuses on developing innovative therapeutic treatments.
Cytokinetics
Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.
Endourage
Endourage is a pharmaceutical company that focuses on developing indication-specific therapeutics for clinical use.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Longitude Capital
Longitude Capital investment in Series C - Zenas BioPharma
Superstring Capital
Superstring Capital investment in Series C - Zenas BioPharma
Enavate Sciences
Enavate Sciences investment in Series C - Zenas BioPharma
Fairmount Funds Management
Fairmount Funds Management investment in Series C - Zenas BioPharma
Wellington Management
Wellington Management investment in Series C - Zenas BioPharma
Rock Springs Capital
Rock Springs Capital investment in Series C - Zenas BioPharma
Federated Hermes
Federated Hermes investment in Series C - Zenas BioPharma
Quan Capital
Quan Capital investment in Series C - Zenas BioPharma
Delos Capital
Delos Capital investment in Series C - Zenas BioPharma
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Series C - Zenas BioPharma
Key Employee Changes
Date | New article |
---|---|
2024-07-01 | Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer |
2022-09-07 | Zenas BioPharma Appoints Simon Lowry, M.D. as Chief Medical Officer |
Official Site Inspections
http://www.zenasbio.com Semrush global rank: 1.89 M Semrush visits lastest month: 11.52 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Zenas BioPharma"
Who We Are - Zenas BioPharma
Zenas BioPharma is committed to being a leader in the development and commercialization of transformative immunology-based therapies.See details»
Contact Us - Zenas BioPharma
Contact Us Corporate Headquarters 852 Winter Street Suite 250 Waltham, MA 02451 Get In Touch For investor- or media-related inquiries, please email [email protected]See details»
Investor & Media Relations | Zenas BioPharma, Inc
May 15, 2025 Zenas BioPharma, Inc Investor relations (IR) website contains information about our business for stockholders, potential investors, and financial analysts.See details»
Zenas BioPharma Announces Key 2024 Accomplishments and 2025
Feb 5, 2025 For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on LinkedIn. Forward looking statementsSee details»
Events & Presentations | Zenas BioPharma, Inc
Dec 3, 2024 Past Events Jefferies Global Healthcare Conference June 5, 2025 1:25 PM EDT View Webcast Guggenheim SMID Cap Biotech Conference February 5, 2025 3:00 PM EST โฆSee details»
Zenas BioPharma Announces Inducement Grant Under Nasdaq โฆ
WALTHAM, Mass., June 20, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (โZenasโ or the โCompanyโ) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company โฆSee details»
Zenas BioPharma (ZBIO) Company Profile & Description
4 days ago Company profile for Zenas BioPharma, Inc. (ZBIO) stock, with a description, list of executives, contact details and other key facts.See details»
Zenas BioPharma Company Profile | Management and Employees โฆ
Find contact information for Zenas BioPharma. Learn about their Research & Development, Business Services market share, competitors, and Zenas BioPharma's email format.See details»
Zenas Biopharma Inc, ZBIO:NSQ profile - FT.com
5 days ago Zenas Biopharma Inc (ZBIO:NSQ) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Zenas BioPharma Appoints Haley Laken, Ph.D., as Chief Scientific โฆ
Apr 7, 2025 Dr. Laken brings over 25 years of leadership experience in research, development operations, scientific assessment and strategyWALTHAM, Mass., April 07, 2025 (GLOBE โฆSee details»
Zenas BioPharma Reports First Quarter 2025 Financial Results and ...
May 15, 2025 - Topline results from pivotal Phase 3 INDIGO trial in Immunoglobulin G4-Related Disease expected around year-end 2025 - - Phase 2 MoonStone trial in Relapsing Multiple โฆSee details»
Zenas BioPharma - LifeScienceHistory.com
Zenas BioPharma is a cross-border (China-USA based) biopharmaceutical company committed to becoming a global leader in the development and delivery of immune-based therapies for โฆSee details»
Zenas BioPharma Company Overview, Contact Details
May 7, 2024 Learn more about Zenas BioPharma's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Zenas BioPharma to Present at the Jefferies Global - GlobeNewswire
May 29, 2025 For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on LinkedIn.See details»
Zenas BioPharma Appoints Haley Laken, Ph.D., as Chief
Apr 7, 2025 For more information about Zenas BioPharma, please visit www.zenasbio.com and follow us on LinkedIn. Forward looking statementsSee details»
Zenas BioPharma Reports Progress in Clinical Trials and ... - Nasdaq
May 15, 2025 Zenas BioPharma reports ongoing Phase 2 and Phase 3 trials, leadership appointments, and financial results for Q1 2025.See details»
Zenas BioPharma - Crunchbase Company Profile & Funding
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.See details»
Zenas BioPharma (ZBIO) Stock Price & Overview
4 days ago A detailed overview of Zenas BioPharma, Inc. (ZBIO) stock, including real-time price, chart, key statistics, news, and more.See details»
Pipeline - Zenas BioPharma
Pipeline Advancing Obexelimab for Patients with Autoimmune Diseases Zenas is committed to being a leader in the development and commercialization of transformative therapies for โฆSee details»
Zenas BioPharma LLC. - Drug pipelines, Patents, Clinical trials
Jun 15, 2025 Our experienced leadership team and network of business partners drive operational excellence to deliver potentially transformative therapies to improve the lives of โฆSee details»